259 related articles for article (PubMed ID: 639368)
1. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
Mimran A; Shaldon S; Barjon P; Mion C
Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
[TBL] [Abstract][Full Text] [Related]
2. [Arterial hypertension and maintenance hemodialysis: effects of specific inhibition of angiotensin II by saralasin acetate].
Mimran A; Deschodt G; Shaldon S; Barjon P; Mion C
Arch Mal Coeur Vaiss; 1978 Jul; 71 Spec No():19-24. PubMed ID: 101176
[TBL] [Abstract][Full Text] [Related]
3. [Effect of the angiotensin antagonist saralasin on blood pressure and hemodynamics in patients with terminal renal insufficiency].
Tuma J; Beckerhoff R; Záruba K; Furrer J; Vetter W
Schweiz Med Wochenschr; 1977 May; 107(20):704-9. PubMed ID: 867013
[TBL] [Abstract][Full Text] [Related]
4. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
[TBL] [Abstract][Full Text] [Related]
5. [Saralasin in subjects with low renin arterial hypertension].
Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
[TBL] [Abstract][Full Text] [Related]
6. The hypertension of long-term hemodialysis patients: studies with an angiotensin II antagonist (P113).
Mimran A; Shaldon S; Mathieu MN; Polito C; Barjon P; Mion C
Trans Am Soc Artif Intern Organs; 1976; 22():9-13. PubMed ID: 951896
[TBL] [Abstract][Full Text] [Related]
7. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
McCaa RE
Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
[TBL] [Abstract][Full Text] [Related]
8. Effect of saralasin on plasma aldosterone in hypertensive man.
Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
[No Abstract] [Full Text] [Related]
9. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
[TBL] [Abstract][Full Text] [Related]
10. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
11. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
[TBL] [Abstract][Full Text] [Related]
12. [Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)].
Nigawara K; Yagihashi Y; Kogawa T; Kawamata A; Yamaya K; Sugawara S; Tulachan Y; Funyu T; Eba H; Kido K; Tanaka T; Morita S; Fukushi M; Furusawa M; Terayama Y; Hirayama N
Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1231-42. PubMed ID: 396404
[No Abstract] [Full Text] [Related]
13. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
[TBL] [Abstract][Full Text] [Related]
14. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
[TBL] [Abstract][Full Text] [Related]
15. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II blockade in hypertensive dialysis patients.
MacGregor GA; Dawes PM
Prog Biochem Pharmacol; 1976; 12():190-9. PubMed ID: 1019164
[TBL] [Abstract][Full Text] [Related]
17. Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin.
Roos JC; Geyskes GG; Boer P; Dorhout Mees EJ
J Cardiovasc Pharmacol; 1981; 3(5):1106-15. PubMed ID: 6168855
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
Higuma K; Fujishima S; Shionoiri H; Tochikubo O; Uneda S; Fujiki Y; Kaneko Y
Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833
[No Abstract] [Full Text] [Related]
19. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
20. The influence of sar1 ala8 angiotensin II (saralasin) on plasma aldosterone in hypertensive patients.
Donker AJ; van Hoogdalem P; Pratt JJ; Leenen FH
Acta Med Scand; 1979; 205(3):207-12. PubMed ID: 425848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
